|
⚲
|
| Keyboard |
| Merck Sharp & Dohme LLC
✚
|
|
|---|---|
| CIK # | 0000942443, 0000064978 |
| Sector | Form 13F Holdings | Value ($M) |
|---|---|---|
| Moderna Inc | 117.3 | |
| Personalis Inc | 89.5 | |
| Kymera Therapeutics Inc | 64.3 | |
| Alector Inc | 7.6 | |
| Sutro Biopharma Inc | 6.8 | |
| Evaxion Biotech A/S | 4.5 | |
| Signal Genetics Inc | 1.8 | |
| Xilio Therapeutics Inc | 0.9 | |
| Bionomics Limited/Fi | 0.0 | |
| Berry Only Inc | 0.0 |
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0000064978] | |
| 3 | [0000064978] | |
| 4 | [0000064978] | |
| SC 13D | [0000064978] | |
| 3 | [0000942443] | |
| 4 | [0000942443] | |
| 5 | [0000942443] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Merck Sharp & Dohme LLC | Harpoon Therapeutics Inc | [2024-01-18] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Harpoon Therapeutics Inc HARP
Common Stock, par value $0.0001
|
2024-03-11 | Buy | 21,397,205 | $23.00 | 492,135,715 |
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2019-04-08 | Conversion | 8,833,333 | ||
|
NGM Biopharmaceuticals Inc NGM
Series E Convertible Preferred Stock · derivative
|
2019-04-08 | Conversion | 17,666,666 | $0.00 | |
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2019-04-08 | Buy | 4,121,683 | $16.00 | 65,946,928 |
|
Sutro Biopharma Inc STRO
Series E Redeemable Convertible Preferred Stock · derivative
|
2018-10-01 | Conversion | 74,794,315 | $0.00 | |
|
Sutro Biopharma Inc STRO
Common Stock
|
2018-10-01 | Buy | 666,666 | $15.00 | 9,999,990 |
|
Sutro Biopharma Inc STRO
Common Stock
|
2018-10-01 | Conversion | 2,056,843 | ||
|
Opgen Inc OPGN
Warrant to Purchase Common Stock · derivative
|
2017-06-28 | Grant | 13,120 | $0.00 | |
|
Opgen Inc OPGN
Common Stock
|
2016-06-27 | Grant | 2,734,427 | ||
|
Opgen Inc OPGN
Warrants · derivative
|
2016-06-27 | Buy | 2,050,821 | ||
|
Opgen Inc OPGN
Common Stock
|
2016-05-19 | Grant | 1,200,000 | ||
|
Opgen Inc OPGN
Common Stock and Warrants (Obligation to buy Units) · derivative
|
2016-05-19 | Buy | 2,734,427 | ||
|
Opgen Inc OPGN
Warrants · derivative
|
2016-05-19 | Buy | 900,000 | ||
|
BeOne Medicines Ltd BGNE
Ordinary Shares
|
2016-02-08 | Other | 7,942,314 | ||
|
BeOne Medicines Ltd BGNE
Ordinary Shares
|
2016-02-08 | Conversion | 18,518,519 | ||
|
BeOne Medicines Ltd BGNE
Ordinary Shares
|
2016-02-08 | Conversion | 5,128,205 | ||
|
BeOne Medicines Ltd BGNE
Series A-2 Preferred Shares · derivative
|
2016-02-08 | Conversion | 5,128,205 | ||
|
BeOne Medicines Ltd BGNE
Series A Preferred Shares · derivative
|
2016-02-08 | Conversion | 18,518,519 |